SightGlass Vision Reports 18-month DOT Lens Data Showing Reduced Myopia Progression
New readout at Academy ’25 adds weight to contrast-modulating spectacle lenses SightGlass Vision (San Ramon, CA, United States) brought fresh…
European Approval for Sydnexis’ Pediatric Myopia Treatment
Sydnexis’ SYD-101 low-dose atropine formulation is now the first pharmaceutical option in Europe for myopia. The European Commission has granted…
latest posts
